Arax Advisory Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.9K Buy
482
+464
+2,578% +$13.3K ﹤0.01% 1817
2025
Q1
$604 Buy
18
+12
+200% +$403 ﹤0.01% 2502
2024
Q4
$307 Buy
+6
New +$307 ﹤0.01% 2371